TRIM47-facilitated PLK1 stabilization promotes the proliferation of liver cancer cells
Cellular Oncology · 2025
DOI: 10.1007/s13402-025-01130-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, 2025. Verfasst von Tao Xie und 11 weiteren Autor:innen. Beteiligte Einrichtung: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Jiangxi Province Key Laboratory of Bioengineering Drugs, …. Hauptthemen laut MEDLINE: Liver Neoplasms, Proto-Oncogene Proteins, Protein Serine-Threonine Kinases, Cell Cycle Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangxi Provincial Key Laboratory of Bioengineering Drugs, Jiangxi Provincial Natural Science Foundation.
Abstract (Originalsprache)
Background
Liver cancer (LC) remains a leading cause of cancer-related mortality worldwide, with limited therapeutic options for advanced-stage disease. While tripartite motif-containing 47 (TRIM47), a typical E3 ubiquitin ligase, has been implicated in cancer progression, its precise role in LC pathogenesis remains unclear.
Methods
TRIM47 expression in hepatocellular carcinoma (HCC) tissues was analyzed through public databases. Functional assays, including TRIM47 knockdown and overexpression experiments, were performed to investigate its impact on cell proliferation, apoptosis and the cell cycle both in vitro and in vivo. The investigation was conducted using a combination of methodologies, including yeast-two hybrid screening, ubiquitination assays, and signaling pathway analyses, to elucidate the underlying mechanisms. In addition, rescue assays were performed to validate the effect of TRIM47-PLK1 axis on LC growth.
Results
TRIM47 was significantly elevated in HCC tissues and positively correlated with advanced clinical stage and poor overall survival. Functionally, TRIM47 knockdown suppressed LC cell growth, while its overexpression promoted tumor proliferation. Furthermore, TRIM47 facilitates cell cycle progression by alleviating G2/M phase arrest and inhibits apoptosis in LC cells. Mechanistically, TRIM47 catalyzes K63-linked ubiquitination of polo-like kinase 1 (PLK1), leading to its stabilization and subsequent activation of the NF-κB and MAPK pathways. Clinical validation confirmed a significant positive correlation between TRIM47 and PLK1 expression in human HCC specimens. Importantly, pharmacological inhibition of PLK1 effectively abrogated TRIM47-driven tumor growth in xenograft models.
Conclusion
This study identifies TRIM47 as a critical regulator of LC progression through PLK1 stabilization and proposes the TRIM47-PLK1 axis as a potential therapeutic target for LC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Jiangxi Province Key Laboratory of Bioengineering Drugs, Institute of Translational Medicine, Jiangxi Medical College, Nanchang…
- School of Basic Medical Sciences, Institute of Biomedical Innovation, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
- School of Future Technology, Nanchang University, Nanchang, China.
- HuanKui Academy, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Department of Anesthesiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. liyong@ncu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Jiangxi Provincial Key Laboratory of Bioengineering Drugs
- Jiangxi Provincial Natural Science Foundation
Zitieren
APA
Xie, T., Fan, X., Yu, T., Zhu, Q., Zhang, Q., Li, N., Wang, T., Qian, Y., Deng, K., Xin, H., Li, Y., & Huang, X. (2025). TRIM47-facilitated PLK1 stabilization promotes the proliferation of liver cancer cells. Cellular Oncology. https://doi.org/10.1007/s13402-025-01130-0
Vancouver
Xie T, Fan X, Yu T, Zhu Q, Zhang Q, Li N, et al. TRIM47-facilitated PLK1 stabilization promotes the proliferation of liver cancer cells. Cellular Oncology. 2025. doi:10.1007/s13402-025-01130-0
BibTeX
@article{Xie2025,
author = {Xie, Tao and Fan, Xiaoqi and Yu, Tian and Zhu, Qing and Zhang, Qi and Li, Na and Wang, Tao and Qian, Yisong and Deng, Keyu and Xin, Hongbo and Li, Yong and Huang, Xuan},
title = {TRIM47-facilitated PLK1 stabilization promotes the proliferation of liver cancer cells},
journal = {Cellular Oncology},
year = {2025},
doi = {10.1007/s13402-025-01130-0}
}
EUVIMED